Word

TIEFENBACHER

Status

Dead

Status Code

602

Status Date

Thursday, March 31, 2022

Serial Number

79296462

Mark Type

4000

Filing Date

Wednesday, August 26, 2020

Abandoned Date

Friday, March 18, 2022

Trademark Owner History

Alfred E. Tiefenbacher GmbH & Co. KG

Classifications

5 Medicinal specialities; generic medicines; pharmaceutical, chemical, biological and biochemical products, preparations and reagents, in particular for medical and diagnostic purposes; microorganisms, proteins, polypeptides, nucleotides, nucleic acids, cell-lines and cells, in particular for medical and diagnostic purposes, for investigation and characterisation of diseases, for medical research and development of medicines and for the manufacture of medicines and pharmaceuticals; sanitary preparations for medical purposes; dietetic preparations adapted for medical use; a full line of pharmaceuticals

1 Chemical, biological and biochemical products, preparations and reagents for scientific, research, laboratory and industrial purposes (other than for medical purposes); micro-organisms, proteins, polypeptides, nucleotides, nucleic acids, cell-lines and cells, in particular for scientific, research, laboratory and industrial purposes, other than for medical purposes; pharmaceutical, chemical, biological and biochemical products, preparations and reagents for researching and characterising diseases, for medical research and medicine development and for manufacturing medicines and pharmaceuticals; Chemical reagents for scientific use; biological diagnostic reagents for clinical or medical laboratory use; chemical preparations for general industrial manufacturing; Cells for scientific and research use; nucleic acid for laboratory use; biochemical, namely, polypeptides for in vitro research use; cultures of micro-organisms, other than for medical use; protein for industrial use, nucleotides for scientific and research use; Chemical additives for use in the manufacture of pharmaceuticals

42 Scientific and technological services, consultancy and research, in particular in the field of medicine, medical diagnostics, pharmacy, molecular biology, biotechnology, immunology and genetics, for medicine development and for manufacturing medicines and pharmaceuticals; scientific and industrial research and development, in particular in the fields of medicine, medical diagnostics, pharmacy, molecular biology, biotechnology, immunology and genetics, for development of medicines and for the manufacture of medicines and pharmaceuticals; investigation and development of medicines, diagnostic and analysis agents and therapy procedures (medical research); pharmaceutical, genealogical, bacteriological, biological, biochemical, chemical, molecular biological and forensic laboratories (other than medical consultancy); scientific experiments and providing scientific expertise in the fields of medicine, medical diagnostics, pharmacy, molecular biology, biotechnology, immunology and genetics, for development of medicines and for the manufacture of medicines and pharmaceuticals; providing of technical information relating to generic medicines; services in relation to and advice on product development and quality maintenance; services of a medical and veterinary laboratory, in particular testing of medicines for others, development of new medicines; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Technical consulting in the field of pharmaceutical studies; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Pharmaceutical research services; pharmaceutical research and development; Technical research in the field of pharmaceutical studies; Research and development in the pharmaceutical and biotechnology fields; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy; Development of pharmaceutical preparations and medicines; pharmaceutical products development; pharmaceutical drug development services; Medical and scientific research, namely, conducting clinical trials for others; Conducting research and clinical trials for others relating to medical devices and pharmaceuticals; conducting clinical trials for others; Consulting services for others in the field of design, planning, and implementation project management of scientific research and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and clinical trials; design and testing for new product development; chemical laboratories; Scientific and technological services, namely, scientific research, analysis, testing in the fields of pharmaceutical and drug development; scientific investigations for medical purposes; quality control for others; pharmaceutical drug development services; consultation in the private label manufacture and custom manufacture of pharmaceuticals and drugs

Trademark Events

Apr 24, 2023

Final Decision Transaction Processed By Ib

Mar 31, 2023

Final Disposition Notice Sent To Ib

Mar 31, 2023

Final Disposition Notice Created, To Be Sent To Ib

Apr 10, 2022

Notification Of Possible Opposition - Processed By Ib

Mar 31, 2022

Abandonment Notice E-Mailed - Failure To Respond

Mar 31, 2022

Abandonment - Failure To Respond Or Late Response

Mar 23, 2022

Notification Of Possible Opposition Sent To Ib

Mar 23, 2022

Notification Of Possible Opposition Created, To Be Sent To Ib

Sep 17, 2021

Notification Of Final Refusal Emailed

Sep 17, 2021

Final Refusal E-Mailed

Sep 17, 2021

Final Refusal Written

Jul 27, 2021

Teas/Email Correspondence Entered

Jul 26, 2021

Correspondence Received In Law Office

Jul 26, 2021

Teas Response To Office Action Received

Jun 5, 2021

New Representative At Ib Received

Feb 14, 2021

Refusal Processed By Ib

Jan 25, 2021

Non-Final Action Mailed - Refusal Sent To Ib

Jan 25, 2021

Refusal Processed By Mpu

Jan 6, 2021

Non-Final Action (Ib Refusal) Prepared For Review

Jan 5, 2021

Non-Final Action Written

Dec 27, 2020

Assigned To Examiner

Oct 30, 2020

Application Filing Receipt Mailed

Oct 26, 2020

New Application Office Supplied Data Entered

Oct 22, 2020

Sn Assigned For Sect 66a Appl From Ib